Stylianos Lefkopoulos (he/him)
@slefkopoulos.bsky.social did:plc:mz4nog7rtfpvxjkjk567dsp7
Senior Editor at @natcellbio.nature.com: #stemcells & #embryo development #disease | proud scientist | 🏳️🌈 gender fluid, antisexist, liberal | 🍫 📚 🐶 🧑🍳 🌱 |📍Berlin | views are his own | call him Stelios
Sur Bluesky depuis le
- Abonnés
- 3 287
- Abonnements
- 361
- Posts
- 231
- Jours dans les classements
- 0
Résumé
Stylianos Lefkopoulos (he/him) (@slefkopoulos.bsky.social) est sur Bluesky depuis le 14 novembre 2024. Le compte a 3 287 abonnés, suit 361 comptes et a publié 231 posts.
Présence dans les classements
Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.
Ce compte n’est encore apparu dans aucun classement quotidien.
Posts aimés récemment
J’aime publics du réseau Bluesky.
It's already been 20 years since Kazutoshi Takahashi and Shinya Yamanaka published their landmark paper on iPSCs in Cell. Amazing how a single publication could spark an entire field! #iPSCell buff.ly/sRzPzBr
Voir le postThis is a very cool paper for those of us studying pregnancy and cancer. Of course, implantation needs to be a dialogue between the decidua and the blastocyst, but now we know some of the sentences they use to talk to each other.....
Voir le postIt was a brilliant opportunity to be able to comment on this latest assembloid story ! Exciting to see the field moving forward !
Voir le postMissed highlighting my choice last week in @science.org Elevated contractility drives implantation failure in mouse embryos from aged females www.nature.com/articles/s41...
Voir le postThe transformative concept of cellular reprogramming is now being applied for in vivo cancer immunotherapy. How might the next 20 years expand reprogramming approaches within the tumor microenvironment? Exciting times ahead! #iPSC #CellularReprogramming #CancerImmunotherapy
Voir le post
Comptes bloqués
Sur Bluesky, les blocages sont publics.
